TWEAK as a target for therapy in systemic lupus erythematosus

By Leng Rui-Xue   Pan Hai-Feng   Qin Wei-Zi   Wang Chao   Chen Li-Li   Tao Jin-Hui   Ye Dong-Qing  

Molecular Biology Reports, Vol. 38, Iss. 1, 2011-01 ,pp. : 587-592

Springer Publishing Company

Access to resources Recommend Favorite

Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus

By Silva Hildson   Silva Alex   Silva Helker   Asano Nadja   Maia Maria   Souza Paulo  

Molecular Biology Reports, Vol. 41, Iss. 4, 2014-04 ,pp. : 2493-2500

Springer Publishing Company

Access to resources Recommend Favorite

Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus

By Iikuni Noriko   H Hahn Bevra   La Cava Antonio  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 201-206

Informa Healthcare

Access to resources Recommend Favorite

Abatacept for systemic lupus erythematosus: the outlook

By Mok Chi Chiu  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1559-1561

Informa Healthcare

Access to resources Recommend Favorite

Belimumab for the management of systemic lupus erythematosus

By Lutalo Pamela M K   D'Cruz David P  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite